Clinical Trial Update: A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA) [Phase 2]

View source ↗

Summary

This document reports a Phase 2a clinical trial evaluating nasal-formulated Foralumab in patients with Multiple System Atrophy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Foralumab Nasal (Foralumab)

Snippet

Sponsor: Tiziana Life Sciences LTD | Conditions: Multiple System Atrophy | Phase 2 | Status: RECRUITING